Pharma Foods International Co Ltd
TSE:2929

Watchlist Manager
Pharma Foods International Co Ltd Logo
Pharma Foods International Co Ltd
TSE:2929
Watchlist
Price: 1 003 JPY 6.93%
Market Cap: 28.2B JPY
Have any thoughts about
Pharma Foods International Co Ltd?
Write Note

Pharma Foods International Co Ltd
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Pharma Foods International Co Ltd
Total Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Pharma Foods International Co Ltd
TSE:2929
Total Liabilities
ÂĄ21.5B
CAGR 3-Years
0%
CAGR 5-Years
31%
CAGR 10-Years
56%
GNI Group Ltd
TSE:2160
Total Liabilities
ÂĄ29.7B
CAGR 3-Years
38%
CAGR 5-Years
26%
CAGR 10-Years
30%
PeptiDream Inc
TSE:4587
Total Liabilities
ÂĄ35B
CAGR 3-Years
123%
CAGR 5-Years
90%
CAGR 10-Years
80%
Takara Bio Inc
TSE:4974
Total Liabilities
ÂĄ9.5B
CAGR 3-Years
-22%
CAGR 5-Years
8%
CAGR 10-Years
3%
S
StemRIM Inc
TSE:4599
Total Liabilities
ÂĄ185.9m
CAGR 3-Years
-4%
CAGR 5-Years
15%
CAGR 10-Years
N/A
C
Cuorips Inc
TSE:4894
Total Liabilities
ÂĄ202.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Pharma Foods International Co Ltd
Glance View

Market Cap
28.1B JPY
Industry
Biotechnology

Pharma Foods International Co., Ltd. engages in the development and sale of functional food materials. The company is headquartered in Kyoto, Kyoto-Fu and currently employs 293 full-time employees. The company went IPO on 2006-06-12. The firm operates through three business segments. The Mail Order segment is engaged in the sale of supplement Tamagosamin, cosmetics Pearl Skin Lanchel and Derma QII Mild Peeling Gel, through advertising media such as televisions and radios. The Functional Materials segment is engaged in the development and sale of functional materials such as GABA, Bonepep, Folic Acid eggs and Chicken Egg Antibody. The firm is also engaged in the planning and sale of original equipment manufacturer (OEM) products such as supplements and beverages. The Biomedical segment is engaged in the antibody contract manufacture business for drug discovery and diagnostics, and life science information (LSI) business for analysis and efficacy evaluation test of materials and products.

Intrinsic Value
2 599.9 JPY
Undervaluation 61%
Intrinsic Value
Price

See Also

What is Pharma Foods International Co Ltd's Total Liabilities?
Total Liabilities
21.5B JPY

Based on the financial report for Oct 31, 2024, Pharma Foods International Co Ltd's Total Liabilities amounts to 21.5B JPY.

What is Pharma Foods International Co Ltd's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
56%

Over the last year, the Total Liabilities growth was -23%.

Back to Top